Search for: "TAKEDA PHARMA V TEVA PHARMA" Results 1 - 20 of 68
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Dec 2019, 9:41 am
  In his reference, the Judge trotted through the English court's and CJEU's case law Article 3(a) - Takeda, Farmitalia, Daiichi, Yeda, Medeva (and its progeny), Actavis v Sanofi, Eli Lilly v HGS, Actavis v Boehringer, - and found that it was clear that something more was required, but what that "something" was was not clear. [read post]
30 Apr 2019, 7:22 am
  This is a different concern to Shingrix where the claim did “necessarily and specifically” (i.e. the test set down by the CJEU in Teva v Gilead) cover the product but included non-medicinal ingredients. [read post]
20 Jul 2011, 4:04 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
25 May 2011, 4:59 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 May 2011, 12:33 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Apr 2011, 4:55 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
12 Apr 2011, 10:07 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
29 Mar 2011, 9:19 pm by Marie Louise
(Kluwer Patent Blog) Prezista (Darunavir) – US: Tibotec files patent infringement complaint against Teva in response to Para IV certification (Patent Docs) Provigil (Modafinil) – US: Apotex’s generic Provigil found not to infringe Cephalon patent (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: CAFC reversed summary judgment of nonobviousness in Duramed v Watson (Patent Docs) (IPBiz) Simcor (Niacin/Simvastatin) – US: Abbott files… [read post]
16 Mar 2011, 3:50 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
25 Jan 2011, 10:58 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
29 Dec 2010, 2:57 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
19 Oct 2010, 10:42 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Sep 2010, 2:40 am by Kelly
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
4 Aug 2010, 12:21 am by Kelly
(FDA Law Blog) Aricept (Donepezil) – US: Teva agrees to dismiss suit with Eisai over Aricept patent (Patent Docs) Carbatrol (Carbamazepine) – US: Patent infringement complaint following a Paragraph IV certification: Shire LLC v. [read post]
3 Jun 2010, 5:35 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]